Mapracorat
- Generic Name
- Mapracorat
- Drug Type
- Small Molecule
- Chemical Formula
- C25H26F4N2O2
- CAS Number
- 887375-26-0
- Unique Ingredient Identifier
- 145V79YBVP
- Background
Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.
Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery
Phase 2
Completed
- Conditions
- CataractInflammation
- Interventions
- Drug: Vehicle for BOL-303242-X
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 415
- Registration Number
- NCT00905450
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath